Manish Kohli
( out of 43 reviews )

Manish Kohli, MD

  • Dr. Manish Kohli graduated in 1990 from the University of Delhi with an Internal Medicine residency training at Cook County Hospital, Chicago from 1993-1996. After completing a 3-year Fellowship in Hematology-Oncology at the University of Arkansas from 1996-99, he joined the Central Arkansas Veteran HealthCare System in Little Rock as Staff physician with a joint appointment at the University of Arkansas for Medical Sciences (UAMS) as Assistant Professor of Medicine. During this time Dr. Kohli authored/co-authored several critical research trials including SWOG-9916, which introduced docetaxel chemotherapy in metastatic castrate resistant stage. In 2005, he joined University of Rochester, New York at the rank of Associate Professor in Medicine in which he oversaw critical areas of genomic and liquid biopsy based research. In June 2008, Dr. Kohli joined Mayo Clinic, Rochester, taking charge to build a comprehensive Genitourinary Oncology translational and clinical research program and was promoted to Consultant/Professor in 2016 in the Department of Oncology. In 2018, he was appointed Vice-Chair of the Department of Genitourinary Oncology and as a Distinguished Moffitt Scholar at the Moffitt Cancer Center, Tampa, also appointed as the Director of the DeBartolo Family Personalized Medicine Institute. He joined Huntsman Cancer Institute-University of Utah in January 2020 as a Presidential Endowed Chair and Professor. Dr. Kohli also holds an Adjunct Faculty rank at the University of Illinois in Urbana Champagne where he works with colleagues on two different RO1s for ultrasensitive liquid biopsy profiling of molecular determinants of a variety of clinical outcomes. His research in advanced prostate cancer focusses on “convergence sciences” which combines population based trials with precision medicine concepts.

    Patient Rating

    4.9 /5
    ( out of 43 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    February 24, 2024
    HUNTSMAN CANCER CENTER

    Not in a rush, answers any question, always with a positive attitude.

    February 23, 2024
    HUNTSMAN CANCER CENTER

    I like Dr. Kohli very much. He will listen to you and make positive suggestions for the best treatment available

    February 23, 2024
    HUNTSMAN CANCER CENTER

    We love Dr. Kohli! He is the best doctor we've had. Wouldn't go to anyone else.

    February 18, 2024
    HUNTSMAN CANCER CENTER

    I thought Dr Kohli was warm, friendly and great at answering our questions and explaining what he felt would be good in attacking the cancer.

    January 27, 2024
    HUNTSMAN CANCER CENTER

    Love Dr Kohli is amazing & kind & caring & so attentive to my questions. His clear & just couldn¿t give high enough score! Grateful that God placed us in his care! Thank you Dr Kohli for always honest, kind & direct answers!

    January 27, 2024
    HUNTSMAN CANCER CENTER

    Dr. Kohli is very personable and listens to all of your questions. He is thorough in his answers. He gives me confidence that we are making the right decision.

    January 13, 2024
    HUNTSMAN CANCER CENTER

    Dr Manish Kohli was amazing, caring & explained clearly the plans & recommendations for Prostate cancer care. It¿s not the best news? But having knowledgeable & supportive, caring team like this makes this journey easier!! Thank you Huntsman!

    December 01, 2023
    HUNTSMAN CANCER CENTER

    Dr. Kohli has been very informative about the treatment needed to help us get through all this. And the staff is so helpful in keeping us straight with all the appointments, when they are, and what they¿re for. Coz when your head is in overload you need extra help

    November 24, 2023
    HUNTSMAN CANCER CENTER

    Dr. Kohli is a very good person. He shoots you straight and doesn¿t sugar coat anything. Very serious Doctor although I was able to make him laugh at my appointment. That made my day!!

    See More Patient Comments

  • Dr. Manish Kohli graduated in 1990 from the University of Delhi with an Internal Medicine residency training at Cook County Hospital, Chicago from 1993-1996. After completing a 3-year Fellowship in Hematology-Oncology at the University of Arkansas from 1996-99, he joined the Central Arkansas Veteran HealthCare System in Little Rock as Staff physician with a joint appointment at the University of Arkansas for Medical Sciences (UAMS) as Assistant Professor of Medicine. During this time Dr. Kohli authored/co-authored several critical research trials including SWOG-9916, which introduced docetaxel chemotherapy in metastatic castrate resistant stage. In 2005, he joined University of Rochester, New York at the rank of Associate Professor in Medicine in which he oversaw critical areas of genomic and liquid biopsy based research. In June 2008, Dr. Kohli joined Mayo Clinic, Rochester, taking charge to build a comprehensive Genitourinary Oncology translational and clinical research program and was promoted to Consultant/Professor in 2016 in the Department of Oncology. In 2018, he was appointed Vice-Chair of the Department of Genitourinary Oncology and as a Distinguished Moffitt Scholar at the Moffitt Cancer Center, Tampa, also appointed as the Director of the DeBartolo Family Personalized Medicine Institute. He joined Huntsman Cancer Institute-University of Utah in January 2020 as a Presidential Endowed Chair and Professor. Dr. Kohli also holds an Adjunct Faculty rank at the University of Illinois in Urbana Champagne where he works with colleagues on two different RO1s for ultrasensitive liquid biopsy profiling of molecular determinants of a variety of clinical outcomes. His research in advanced prostate cancer focusses on “convergence sciences” which combines population based trials with precision medicine concepts.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions Oncology

  • News & Podcasts

    Huntsman Cancer Institute News